Interview: Abdelmajid Belaiche – CEO, Moroccan Pharmaceutical Industry Association (AMIP)
20.05.2015
Related Interviews
Pierre Labbé – General Manager, Maphar & CFAO Healthcare Maghreb
Maphar, a 72-year mainstay of the Moroccan pharma industry with both production and distribution arms, has achieved considerable success in recent years, expanding its international network to now reach over…
Fadela Benjelloun – Executive Director, LEMM, Morocco
Fadela Benjelloun, executive director of LEMM, the association of multinational pharma companies in Morocco, looks back on the evolution of the Moroccan pharma market over the past three years, examines…
Marc Funk – CEO, Recipharm & Younès Hillali, General Manager, MARBIO
MARBIO, a new vaccine manufacturing joint venture in Morocco, is the result of a partnership between the BAB banking consortium (Bank of Africa, Banque Centrale Populaire, and Attijariwafa Bank), Swedish…
Belgium / Seven Sector Agenda Priorities
Representatives of Belgian associations for innovative pharma, generics and biosimilars, medtech, OTC, biotech, hospitals, and medical professionals share their key agenda priorities. These include where they feel that change is…
USA / New BIO Board Chair’s Full Task List
During the ongoing BIO International Convention in Boston between June 5th and 8th, the US lobbying group has announced a new board chair in Ted Love as well as a…
UK / AbbVie & Lilly Exit Voluntary Pricing; Moderna Joins ABPI; Biotech Funding Downturn; Gilead NICE Approval
A roundup of the latest UK healthcare, pharma and biotech news including AbbVie and Lilly’s departure from the country’s voluntary medicines pricing agreement, Moderna’s expanded footprint, UK biotech’s 2022 funding…
